Skip to content

Study on the effect of Daoyin on the prevention and treatment of ametropia

Study on the effect of Daoyin on the prevention and treatment of ametropia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041473
Enrollment
Unknown
Registered
2020-12-26
Start date
2020-12-31
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ametropia

Interventions

Daoyin group:Daoyin Mingmugong
eye-caring exercises group:eye-caring exercises
Normal group:Nil

Sponsors

Northwestern Polytechnical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patients were clinically diagnosed as ametropia at home and abroad, and there were clear diagnostic criteria. 2. The age of the patients was 5-85 years old.

Exclusion criteria

Exclusion criteria: 1. Other therapies, such as guiding health care with other therapeutic means (including Traditional Chinese medicine, massage, acupuncture, etc.). 2. Had eye surgery. 3. Those who wear rigid contact lenses.

Design outcomes

Primary

MeasureTime frame
unaided visual acuity;axial length;anterior chamber depth;corneal curvature;diopter;

Secondary

MeasureTime frame
Practice score;

Countries

China

Contacts

Public ContactJiansheng Wen

Northwestern Polytechnical University

wenjiansheng@nwpu.edu.cn+86 13659190126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026